The Long Run with Luke Timmerman
Ep135: John Maraganore on Developing a New Class of Medicines
Dienstag, 9. Mai 2023 · 1 h 04
Kapitelklicken springt direkt hin
Shownotes
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
